Contacts

MedinCell: SAIVE Study data to be presented at ECCMID 2023 

April 17, 2023

Results of the SAIVE study demonstrating good tolerability as well as statistically significant efficacy of Ivermectin vs placebo in the prevention of post-exposure COVID-19 infection will be communicated by MedinCell on April 18, 2023 at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (Copenhagen, Denmark, 15 – 18 April, 2023)

Session en français

Rendez-vous le mardi 12 septembre à 18h00 pour la diffusion en direct de l'Assemblée Générale mixte

English session

On Tuesday September 12 at 6:00 p.m. live of the Combined General Meeting (in French)

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.